title: Topical 0.2% rapamycin to treat facial angiofibromas and hypomelanotic macules in tuberous sclerosis.
authors.affiliation: Servicio de Dermatología, Hospital Universitario Son Espases, Palma de Mallorca, España.
authors.forename: N
authors.initials: N
authors.lastname: Knöpfel
authors.affiliation: Servicio de Dermatología, Hospital Universitario Son Espases, Palma de Mallorca, España. Electronic address: anahsd@telefonica.net.
authors.forename: A
authors.initials: A
authors.lastname: Martín-Santiago
authors.affiliation: Servicio de Dermatología, Hospital Universitario Son Espases, Palma de Mallorca, España.
authors.forename: A
authors.initials: A
authors.lastname: Bauza
authors.affiliation: Instituto Universitario de Ciencias de la Salud-IUNICS, Universidad de las Islas Baleares, Palma de Mallorca, España.
authors.forename: J A
authors.initials: JA
authors.lastname: Hervás
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D018322:Angiofibroma / Q000188:drug therapy*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D005153:Facial Neoplasms / Q000188:drug therapy*; D006801:Humans; D017496:Hypopigmentation / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D020123:Sirolimus / Q000008:administration & dosage*; D014402:Tuberous Sclerosis / Q000150:complications*
chemical_list: D000903:Antibiotics, Antineoplastic; D020123:Sirolimus